SAN DIEGO--(BUSINESS WIRE)--Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in identification of target populations for high value therapeutics, today announced the availability of genomic DNA from the world’s largest bank of viable cryopreserved tumor cells.
